Localized mammographic density is associated with interval cancer and large breast cancer: a nested case-control study.
Breast
/ diagnostic imaging
Breast Density
Breast Neoplasms
/ diagnostic imaging
Case-Control Studies
Delayed Diagnosis
/ prevention & control
Early Detection of Cancer
/ methods
False Negative Reactions
Female
Humans
Image Processing, Computer-Assisted
/ methods
Mammography
/ methods
Mass Screening
/ methods
Middle Aged
Prospective Studies
Retrospective Studies
Time Factors
Tumor Burden
Breast cancer
Early detection
Mammographic density
Mammography
Screening
Journal
Breast cancer research : BCR
ISSN: 1465-542X
Titre abrégé: Breast Cancer Res
Pays: England
ID NLM: 100927353
Informations de publication
Date de publication:
22 01 2019
22 01 2019
Historique:
received:
11
09
2018
accepted:
10
01
2019
entrez:
24
1
2019
pubmed:
24
1
2019
medline:
23
7
2019
Statut:
epublish
Résumé
High mammographic density is associated with breast cancer and with delayed detection. We have examined whether localized density, at the site of the subsequent cancer, is independently associated with being diagnosed with a large-sized or interval breast cancer. Within a prospective cohort of 63,130 women, we examined 891 women who were diagnosed with incident breast cancer. For 386 women, retrospective localized density assessment was possible. The main outcomes were interval cancer vs. screen-detected cancer and large (> 2 cm) vs. small cancer. In negative screening mammograms, overall and localized density were classified reflecting the BI-RADS standard. Density concordance probabilities were estimated through multinomial regression. The associations between localized density and the two outcomes were modeled through logistic regression, adjusted for overall density, age, body mass index, and other characteristics. The probabilities of concordant localized density were 0.35, 0.60, 0.38, and 0.32 for overall categories "A," "B," "C," and "D." Overall density was associated with large cancer, comparing density category D to A with OR 4.6 (95%CI 1.8-11.6) and with interval cancer OR 31.5 (95%CI 10.9-92) among all women. Localized density was associated with large cancer at diagnosis with OR 11.8 (95%CI 2.7-51.8) among all women and associated with first-year interval cancer with OR 6.4 (0.7 to 58.7) with a significant linear trend p = 0.027. Overall density often misrepresents localized density at the site where cancer subsequently arises. High localized density is associated with interval cancer and with large cancer. Our findings support the continued effort to develop and examine computer-based measures of localized density for use in personalized breast cancer screening.
Sections du résumé
BACKGROUND
High mammographic density is associated with breast cancer and with delayed detection. We have examined whether localized density, at the site of the subsequent cancer, is independently associated with being diagnosed with a large-sized or interval breast cancer.
METHODS
Within a prospective cohort of 63,130 women, we examined 891 women who were diagnosed with incident breast cancer. For 386 women, retrospective localized density assessment was possible. The main outcomes were interval cancer vs. screen-detected cancer and large (> 2 cm) vs. small cancer. In negative screening mammograms, overall and localized density were classified reflecting the BI-RADS standard. Density concordance probabilities were estimated through multinomial regression. The associations between localized density and the two outcomes were modeled through logistic regression, adjusted for overall density, age, body mass index, and other characteristics.
RESULTS
The probabilities of concordant localized density were 0.35, 0.60, 0.38, and 0.32 for overall categories "A," "B," "C," and "D." Overall density was associated with large cancer, comparing density category D to A with OR 4.6 (95%CI 1.8-11.6) and with interval cancer OR 31.5 (95%CI 10.9-92) among all women. Localized density was associated with large cancer at diagnosis with OR 11.8 (95%CI 2.7-51.8) among all women and associated with first-year interval cancer with OR 6.4 (0.7 to 58.7) with a significant linear trend p = 0.027.
CONCLUSIONS
Overall density often misrepresents localized density at the site where cancer subsequently arises. High localized density is associated with interval cancer and with large cancer. Our findings support the continued effort to develop and examine computer-based measures of localized density for use in personalized breast cancer screening.
Identifiants
pubmed: 30670066
doi: 10.1186/s13058-019-1099-y
pii: 10.1186/s13058-019-1099-y
pmc: PMC6341532
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
8Références
Breast Cancer Res Treat. 2017 Apr;162(3):541-548
pubmed: 28161786
Med Phys. 2016 Mar;43(3):1249-58
pubmed: 26936709
Br J Cancer. 1981 Aug;44(2):177-81
pubmed: 7272186
Cancer Epidemiol Biomarkers Prev. 2011 Aug;20(8):1718-25
pubmed: 21693627
N Engl J Med. 2007 Jan 18;356(3):227-36
pubmed: 17229950
Ann Surg Oncol. 2010 Jun;17(6):1471-4
pubmed: 20180029
Cancer Causes Control. 2011 Jan;22(1):23-31
pubmed: 20978835
Lancet Oncol. 2005 Oct;6(10):798-808
pubmed: 16198986
Eur J Epidemiol. 1998 Jun;14(4):315-20
pubmed: 9690746
Breast Cancer Res. 2016 Jan 08;18(1):5
pubmed: 26747277
Cancer. 1989 Jan 1;63(1):181-7
pubmed: 2910416
BMC Med. 2006 Dec 26;4(1):38
pubmed: 17190588
Cancer Discov. 2012 Sep;2(9):826-39
pubmed: 22777768
J Clin Oncol. 2015 Mar 20;33(9):1030-7
pubmed: 25646195
Breast Cancer Res. 2018 Apr 18;20(1):31
pubmed: 29669579
Breast Cancer Res. 2005;7(5):R605-8
pubmed: 16168104
Breast Cancer Res Treat. 2018 Jun;169(2):371-379
pubmed: 29392583
Breast Cancer Res. 2013 Jan 29;15(1):R9
pubmed: 23360535
J Natl Cancer Inst. 2004 Oct 6;96(19):1432-40
pubmed: 15467032
Breast Cancer Res. 2013 Jun 20;15(3):R48
pubmed: 23786804
Radiology. 2004 Jan;230(1):42-8
pubmed: 14695385
Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):662-8
pubmed: 15767347
PLoS One. 2014 Oct 21;9(10):e110207
pubmed: 25333936
Swiss Surg. 1999;5(5):199-204
pubmed: 10546517
Phys Med Biol. 2007 Oct 7;52(19):5881-95
pubmed: 17881806
J Natl Cancer Inst. 2000 Jul 5;92(13):1081-7
pubmed: 10880551
Cancer Epidemiol Biomarkers Prev. 2013 Nov;22(11):2116-20
pubmed: 24019394
Clin Cancer Res. 1999 Oct;5(10):2682-8
pubmed: 10537329
Ann Intern Med. 2015 May 19;162(10):673-81
pubmed: 25984843
Int J Epidemiol. 2017 Dec 1;46(6):1740-1741g
pubmed: 28180256
BMJ. 2012 Nov 16;345:e7536
pubmed: 23160783
Ann Intern Med. 2016 Feb 16;164(4):299-300
pubmed: 26757338
Lancet. 2012 Nov 17;380(9855):1778-86
pubmed: 23117178